Sorafenib

Expert Opinion on Pharmacotherapy
Brian I Rini

Abstract

Sorafenib is a small molecule inhibitor of several kinases involved in tumour proliferation and tumour angiogenesis including Raf, VEGFR and platelet derived growth factor receptor. In vivo Raf kinase inhibition has been observed in pharmacodynamic studies. Sorafenib is one of several VEGF-targeting compounds with recently demonstrated substantial anti-tumour effects in metastatic renal cell carcinoma. Delay in time to disease progression has been demonstrated in cytokine-refractory metastatic renal cell carcinoma, and further investigation is ongoing in a wide variety of tumour types. Sorafenib is well tolerated, with common toxicities including rash, diarrhoea, hand-foot skin reaction, fatigue and hypertension, when administered as the standard dose of 400 mg b.i.d.

References

Jan 1, 1990·The Journal of Urology·D M NanusA P Albino
May 1, 1994·Nature Genetics·J R GnarraF M Duh
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·J G HermanW M Linehan
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·R K JainE Keshet
Sep 18, 1998·Biochimica Et Biophysica Acta·C H HeldinL Rönnstrand
Sep 22, 2001·Endocrine-related Cancer·J F LyonsG Bollag
Oct 9, 2002·Current Pharmaceutical Design·Scott Wilhelm, Du-Shieng Chien
Dec 11, 2002·Expert Opinion on Therapeutic Targets·John T Lee, James A McCubrey
Aug 2, 2003·The New England Journal of Medicine·James C YangSteven A Rosenberg
Dec 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel J Hicklin, Lee M Ellis
Dec 23, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk StrumbergSiegfried Seeber
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey W ClarkHeinz-Josef Lenz
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Muralidhar BeeramEric K Rowinsky
Dec 14, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E A Boyce, E C Kohn

❮ Previous
Next ❯

Citations

Nov 7, 2008·Histochemistry and Cell Biology·Girieca Lorusso, Curzio Rüegg
Jun 18, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Hernán Cortés-Funes
May 21, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Nicholas Butowski
Feb 4, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Bella PajaresEmilio Alba
Mar 24, 2011·The Cancer Journal·Armin GergerHeinz-Josef Lenz
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guo ZhangPaul Dent
Nov 10, 2010·Breast Cancer Research : BCR·Ricardo H Alvarez
Mar 15, 2012·World Journal of Gastroenterology : WJG·Daniel Ansari, Roland Andersson
May 11, 2012·Future Medicinal Chemistry·Máximo de la VegaRicardo H Alvarez
Feb 22, 2014·Expert Review of Anticancer Therapy·Stefano RadaelliAlessandro Gronchi
Nov 3, 2006·Expert Review of Neurotherapeutics·Jan Drappatz, Patrick Y Wen
May 12, 2007·Expert Review of Anticancer Therapy·Ferdy J LejeuneDaniel Speiser
May 18, 2010·Expert Opinion on Investigational Drugs·Melissa TaylorFrançoise Farace
Mar 8, 2012·Expert Opinion on Investigational Drugs·Joanna ManganaReinhard Dummer
May 17, 2013·Expert Opinion on Investigational Drugs·Umberto Leone Roberti MaggioreSimone Ferrero
Apr 20, 2007·BJU International·Nicholas J Vogelzang, Cora N Sternberg
Nov 1, 2006·Cancer·Toni K ChoueiriRonald M Bukowski
Mar 22, 2016·Expert Opinion on Investigational Drugs·Massimo GentileFortunato Morabito
Nov 26, 2015·Melanoma Management·Jennifer McQuade, Michael A Davies
Nov 6, 2014·Molecular Medicine Reports·You Cheng ZhangFeng Xian Wei
Mar 25, 2016·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Yaakov CassAlexander Tabachnik
Jun 19, 2008·Nature Clinical Practice. Oncology·Cristiana SessaCurzio Rüegg
Aug 15, 2006·Current Opinion in Urology·Andrea Mancuso, Cora N Sternberg
May 7, 2008·Journal of Cellular Biochemistry·Jessica PlatiRoya Khosravi-Far
Aug 9, 2006·International Journal of Cancer. Journal International Du Cancer·Ralf Schreck, Ulf R Rapp
Aug 4, 2009·The Oncologist·AeRang KimBrigitte C Widemann
Oct 9, 2008·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·R N KeswaniM Bissonnette
Jun 17, 2020·Chemical Society Reviews·Saeid KargozarMasoud Mozafari
Aug 6, 2008·Journal of Medicinal Chemistry·Alejandro CrespoAriel Fernández

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved